Digipath (DIGP) 0.0450 $DIGP
Cannabis for Pennies per Gram and Lobbying for Patient Safety Now on DigiPath's TNMNews.com
PR Newswire - Thu Nov 13, 5:00AM CST
The National Marijuana News, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), has just released its fifth unbiased cannabis news segment, which focuses on radical changes on the horizon for the cannabis industry. Interview guests include Taylor West, Deputy Director for the National Cannabis Industry Association (NCIA), and one of the most recognized personalities in the marijuana industry, Cheryl Shuman. The audio segments are available at www.tnmnews.com.
Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 75.63 (-0.21)
DigiPath announces grant of Nevada State's approval for new medical Cannabis testing lab in Las Vegas
M2 - Fri Nov 07, 6:27AM CST
Cannabis testing firm DigiPath (OTCBB
IGP)(OTCQB IGP) revealed on Thursday the receipt of approval from the State of Nevada to open and operate a new cannabis testing laboratory in Las Vegas, Nevada.
DigiPath Receives Nevada State Approval for Cannabis Testing Lab in Las Vegas
PR Newswire - Thu Nov 06, 8:00AM CST
DigiPath, Inc. (OTCBB and OTCQB: DIGP), an independent cannabis testing and media firm, announced today that it has received approval from the State of Nevada for its DigiPath Labs subsidiary to open and operate a cannabis testing laboratory at 6450 Cameron Street, Suite 113, in Las Vegas, Nevada.
Cannabis Stocks Move Lower as Mid-terms Approach
ACCESSWIRE - Tue Nov 04, 8:02AM CST
Whitefish, MT / November 4, 2014 / Cannabis stocks moved lower last week and early this week, according to data from the Marijuana Index(TM). Top gainers included Endexx Corporation (OTC: EDXC), which is trading up more than 35% since last Monday, despite having no recent press releases. Industry bellwethers like GW Pharmaceuticals plc (NASDAQ: GWPH) were trading largely even for the week, as of mid-day trading on Monday.
GWPH: 75.63 (-0.21), MGW.VN: 0.050 (+0.005)
DigiPath Explores Cannabis in Midterm Election Politics in New TNMNews Segment
PR Newswire - Thu Oct 30, 5:00AM CDT
The National Marijuana News, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), has just released its special midterm election edition of its popular, unbiased cannabis news program on www.TNMNews.com.
DigiPath PathScope hardware to be used at Kadisco General Hospital in Ethiopia to help doctors diagnose cervical and breast cancers, HIV/AIDS and STIs
M2 - Fri Oct 24, 7:55AM CDT
Provider of digital pathology solutions DigiPath Corp, a subsidiary of DigiPath Inc (OTCBB and OTCQB: DIGP), announced on Friday that its PathScope solution has been selected to to improve patient care in Ethiopia.
DigiPath Corp Expands Global Reach, Provides Pathology Solutions to USAID in Ethiopia
PR Newswire - Fri Oct 24, 5:00AM CDT
DigiPath Corp, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and other services to the cannabis industry, is expanding abroad to bring its cutting-edge PathScope(TM) to improve patient care in Ethiopia. DigiPath's PathScope(TM) hardware will be used by Kadisco General Hospital in Ethiopia via a grant funded by the HANSHEP Health Enterprise Fund and implemented by USAID's SHOPS project.
Cannabis Stocks Move Lower After Poor Data at GW Pharma
ACCESSWIRE - Mon Oct 20, 9:33AM CDT
Whitefish, MT / ACCESSWIRE / October 20, 2014 / Cannabis stocks moved largely lower over the past week, led by a 12% drop in GW Pharmaceuticals plc (NASDAQ: GWPH). The company's Phase IIA study of GWP42003 - a CBD-based compound - for ulcerative colitis failed to meet the primary endpoint of disease remission. While second endpoints were promising, the drug also showed poor toleration among patients with a number withdrawing.
GWPH: 75.63 (-0.21)
DigiPath Corp Collaborates with Penn State College of Engineering on Product Design Improvement Project
PR Newswire - Thu Oct 16, 5:00AM CDT
DigiPath Corp, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider, is sponsoring a senior capstone design project through The Learning Factory at the Penn State College of Engineering, over the duration of the Fall 2014 semester.
Special Edition of The National Marijuana News Features an Exclusive Interview with High Times Magazine Cofounder Michael Kennedy
PR Newswire - Tue Oct 14, 5:00AM CDT
Starting today, a special edition of The National Marijuana News is available at www.TNMNews.com. This episode features former Howard Stern Show writer/personality and current TNMNews East Coast Correspondent Jackie Martling's interview with High Times Magazine cofounder and general counsel Michael Kennedy. The show will also be available at Live365.com.
DigiPath Inc. Cofounder Todd Denkin Takes Over as CEO and President
PR Newswire - Mon Oct 06, 8:30AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and related services, has appointed its cofounder Todd Denkin CEO and president. Denkin is taking the reins from Joe Tanner, who is staying onboard as a consultant, but is leaving the senior executive position to spend more time with his family.
DigiPath, Inc., Completes Management Restructuring with Three Senior Appointments
PR Newswire - Mon Aug 25, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and other services to the cannabis industry, announced three top-level appointments today, completing its management restructuring plan.
Global Digital Pathology Market 2014-2018 - Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage
M2 - Tue Aug 19, 5:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ggtzl3/digital_pathology) has announced the addition of the "Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Global Forecasts & Trends to 2018" report to their offering. This report categorizes the global digital pathology market into different products and applications. Scanners accounted for the largest share of the digital pathology products market, followed by analytics. The analytics market is expected to grow at the highest CAGR of 12.4% from 2013 to 2018. The high growth can be attributed to the growing importance of image analysis software that is increasingly being used to understand cancer complexity and the drive for personalized medicine, among others. This report covers the definition, description, and forecast of the global market in terms of products, applications, and geographies. The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The dominance of the North American market can be attributed to reasons such as the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, the Asian market is expected to experience the highest growth in the market. The high growth in the Asian region can be attributed to the rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the uses to improve the quality of cancer diagnosis. Some of the prominent players in the global market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Digital Pathology: Rationale for Adoption 5 Global Digital Pathology Market, By Product 6 Global Digital Pathology Market, By Application 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - 3dhistech Ltd. - Apollo Pacs, Inc. - Aurora Interactive Ltd. - Corista LLC - Definiens AG - Digipath, Inc. - Hamamatsu Photonics K.K. - Huron Technologies International, Inc. - Indica Labs, Inc. - Kanteron Systems - Leica Biosystems, Gmbh - Ligolab, LLC - Mikroscan Technologies, Inc. - Nikon Instruments, Inc. - Objective Pathology Services, Ltd. - Omnyx, LLC - Pathxl, Ltd. - Pixcelldata, Ltd. - Sunquest Information Systems, Inc. - Ventana Medical Systems, Inc. - Visiopharm - Xifin, Inc. For more information visit http://www.researchandmarkets.com/research/gg..._pathology
DigiPath's Dr. Cindy Orser Speaks on the Importance of Adopting Cannabis Standards August 14, 2014
PR Newswire - Tue Aug 05, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into the cannabis testing and education markets, announced today that Cindy Orser, Ph.D. will lead an introductory webinar on the importance of standards in the cannabis industry on Thursday, August 14, 2014. The key issue of adopting standards is the second in a five-week series of webinars collectively titled: "Cannabis 2.0: Making It in the Emerging Marijuana Industry," which begins on August 7th.
DigiPath No New Corporate Developments
PR Newswire - Wed Jul 30, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced today that has been no material development in its business and affairs not previously disclosed or, to its knowledge, any other reason to account for the recent unusual market action.
OTC Trading Stock News: Digipath, Inc. Immune Pharmaceuticals, Inc. Vuzix Corp, Nuvilex, Inc. Origin Oil, Inc.
PR Newswire Europe - Tue Jul 29, 7:07AM CDT
LONDON, July 29, 2014 /PRNewswire/ --
IMNP: 2.91 (+0.12)
Cannabis Stocks Moved Lower Last Week, but Novus & Terra Tech Were Smokin'
ACCESSWIRE - Mon Jul 28, 8:33AM CDT
WHITEFISH, MT / July 28, 2014 / The Marijuana Index(TM) moved lower last week after a modest 1.6% rise in bellwether GW Pharmaceuticals plc (NASDAQ: GWPH) was offset by a significant 4.9% drop in MedBox Inc. (OTC: MDBX) shares.
GWPH: 75.63 (-0.21)
DigiPath Raises $8.2 Million to Expand into Cannabis Industry
ACCESSWIRE - Fri Jul 25, 8:41AM CDT
WHITEFISH, MT / July 25, 2014 / The U.S. cannabis industry grew 64% in 2013 and is expected to reach $2.34 billion by the end of 2014, according to ArcView Market Research. So far, 23 U.S. states and Washington D.C. have legalized medical marijuana, while Colorado and Washington State have legalized recreational marijuana. These trends are poised to continue in the November general election with several outstanding ballot measures in place.
GWPH: 75.63 (-0.21), SIRI: 3.53 (+0.02), GPX: 32.01 (+0.44)
Cannabis for Pennies per Gram and Lobbying for Patient Safety Now on DigiPath's TNMNews.com
PR Newswire - Thu Nov 13, 5:00AM CST
The National Marijuana News, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), has just released its fifth unbiased cannabis news segment, which focuses on radical changes on the horizon for the cannabis industry. Interview guests include Taylor West, Deputy Director for the National Cannabis Industry Association (NCIA), and one of the most recognized personalities in the marijuana industry, Cheryl Shuman. The audio segments are available at www.tnmnews.com.
Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 75.63 (-0.21)
DigiPath announces grant of Nevada State's approval for new medical Cannabis testing lab in Las Vegas
M2 - Fri Nov 07, 6:27AM CST
Cannabis testing firm DigiPath (OTCBB
IGP)(OTCQB IGP) revealed on Thursday the receipt of approval from the State of Nevada to open and operate a new cannabis testing laboratory in Las Vegas, Nevada. DigiPath Receives Nevada State Approval for Cannabis Testing Lab in Las Vegas
PR Newswire - Thu Nov 06, 8:00AM CST
DigiPath, Inc. (OTCBB and OTCQB: DIGP), an independent cannabis testing and media firm, announced today that it has received approval from the State of Nevada for its DigiPath Labs subsidiary to open and operate a cannabis testing laboratory at 6450 Cameron Street, Suite 113, in Las Vegas, Nevada.
Cannabis Stocks Move Lower as Mid-terms Approach
ACCESSWIRE - Tue Nov 04, 8:02AM CST
Whitefish, MT / November 4, 2014 / Cannabis stocks moved lower last week and early this week, according to data from the Marijuana Index(TM). Top gainers included Endexx Corporation (OTC: EDXC), which is trading up more than 35% since last Monday, despite having no recent press releases. Industry bellwethers like GW Pharmaceuticals plc (NASDAQ: GWPH) were trading largely even for the week, as of mid-day trading on Monday.
GWPH: 75.63 (-0.21), MGW.VN: 0.050 (+0.005)
DigiPath Explores Cannabis in Midterm Election Politics in New TNMNews Segment
PR Newswire - Thu Oct 30, 5:00AM CDT
The National Marijuana News, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), has just released its special midterm election edition of its popular, unbiased cannabis news program on www.TNMNews.com.
DigiPath PathScope hardware to be used at Kadisco General Hospital in Ethiopia to help doctors diagnose cervical and breast cancers, HIV/AIDS and STIs
M2 - Fri Oct 24, 7:55AM CDT
Provider of digital pathology solutions DigiPath Corp, a subsidiary of DigiPath Inc (OTCBB and OTCQB: DIGP), announced on Friday that its PathScope solution has been selected to to improve patient care in Ethiopia.
DigiPath Corp Expands Global Reach, Provides Pathology Solutions to USAID in Ethiopia
PR Newswire - Fri Oct 24, 5:00AM CDT
DigiPath Corp, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and other services to the cannabis industry, is expanding abroad to bring its cutting-edge PathScope(TM) to improve patient care in Ethiopia. DigiPath's PathScope(TM) hardware will be used by Kadisco General Hospital in Ethiopia via a grant funded by the HANSHEP Health Enterprise Fund and implemented by USAID's SHOPS project.
Cannabis Stocks Move Lower After Poor Data at GW Pharma
ACCESSWIRE - Mon Oct 20, 9:33AM CDT
Whitefish, MT / ACCESSWIRE / October 20, 2014 / Cannabis stocks moved largely lower over the past week, led by a 12% drop in GW Pharmaceuticals plc (NASDAQ: GWPH). The company's Phase IIA study of GWP42003 - a CBD-based compound - for ulcerative colitis failed to meet the primary endpoint of disease remission. While second endpoints were promising, the drug also showed poor toleration among patients with a number withdrawing.
GWPH: 75.63 (-0.21)
DigiPath Corp Collaborates with Penn State College of Engineering on Product Design Improvement Project
PR Newswire - Thu Oct 16, 5:00AM CDT
DigiPath Corp, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider, is sponsoring a senior capstone design project through The Learning Factory at the Penn State College of Engineering, over the duration of the Fall 2014 semester.
Special Edition of The National Marijuana News Features an Exclusive Interview with High Times Magazine Cofounder Michael Kennedy
PR Newswire - Tue Oct 14, 5:00AM CDT
Starting today, a special edition of The National Marijuana News is available at www.TNMNews.com. This episode features former Howard Stern Show writer/personality and current TNMNews East Coast Correspondent Jackie Martling's interview with High Times Magazine cofounder and general counsel Michael Kennedy. The show will also be available at Live365.com.
DigiPath Inc. Cofounder Todd Denkin Takes Over as CEO and President
PR Newswire - Mon Oct 06, 8:30AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and related services, has appointed its cofounder Todd Denkin CEO and president. Denkin is taking the reins from Joe Tanner, who is staying onboard as a consultant, but is leaving the senior executive position to spend more time with his family.
DigiPath, Inc., Completes Management Restructuring with Three Senior Appointments
PR Newswire - Mon Aug 25, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and other services to the cannabis industry, announced three top-level appointments today, completing its management restructuring plan.
Global Digital Pathology Market 2014-2018 - Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage
M2 - Tue Aug 19, 5:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ggtzl3/digital_pathology) has announced the addition of the "Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Global Forecasts & Trends to 2018" report to their offering. This report categorizes the global digital pathology market into different products and applications. Scanners accounted for the largest share of the digital pathology products market, followed by analytics. The analytics market is expected to grow at the highest CAGR of 12.4% from 2013 to 2018. The high growth can be attributed to the growing importance of image analysis software that is increasingly being used to understand cancer complexity and the drive for personalized medicine, among others. This report covers the definition, description, and forecast of the global market in terms of products, applications, and geographies. The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The dominance of the North American market can be attributed to reasons such as the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, the Asian market is expected to experience the highest growth in the market. The high growth in the Asian region can be attributed to the rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the uses to improve the quality of cancer diagnosis. Some of the prominent players in the global market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Digital Pathology: Rationale for Adoption 5 Global Digital Pathology Market, By Product 6 Global Digital Pathology Market, By Application 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - 3dhistech Ltd. - Apollo Pacs, Inc. - Aurora Interactive Ltd. - Corista LLC - Definiens AG - Digipath, Inc. - Hamamatsu Photonics K.K. - Huron Technologies International, Inc. - Indica Labs, Inc. - Kanteron Systems - Leica Biosystems, Gmbh - Ligolab, LLC - Mikroscan Technologies, Inc. - Nikon Instruments, Inc. - Objective Pathology Services, Ltd. - Omnyx, LLC - Pathxl, Ltd. - Pixcelldata, Ltd. - Sunquest Information Systems, Inc. - Ventana Medical Systems, Inc. - Visiopharm - Xifin, Inc. For more information visit http://www.researchandmarkets.com/research/gg..._pathology
DigiPath's Dr. Cindy Orser Speaks on the Importance of Adopting Cannabis Standards August 14, 2014
PR Newswire - Tue Aug 05, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into the cannabis testing and education markets, announced today that Cindy Orser, Ph.D. will lead an introductory webinar on the importance of standards in the cannabis industry on Thursday, August 14, 2014. The key issue of adopting standards is the second in a five-week series of webinars collectively titled: "Cannabis 2.0: Making It in the Emerging Marijuana Industry," which begins on August 7th.
DigiPath No New Corporate Developments
PR Newswire - Wed Jul 30, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced today that has been no material development in its business and affairs not previously disclosed or, to its knowledge, any other reason to account for the recent unusual market action.
OTC Trading Stock News: Digipath, Inc. Immune Pharmaceuticals, Inc. Vuzix Corp, Nuvilex, Inc. Origin Oil, Inc.
PR Newswire Europe - Tue Jul 29, 7:07AM CDT
LONDON, July 29, 2014 /PRNewswire/ --
IMNP: 2.91 (+0.12)
Cannabis Stocks Moved Lower Last Week, but Novus & Terra Tech Were Smokin'
ACCESSWIRE - Mon Jul 28, 8:33AM CDT
WHITEFISH, MT / July 28, 2014 / The Marijuana Index(TM) moved lower last week after a modest 1.6% rise in bellwether GW Pharmaceuticals plc (NASDAQ: GWPH) was offset by a significant 4.9% drop in MedBox Inc. (OTC: MDBX) shares.
GWPH: 75.63 (-0.21)
DigiPath Raises $8.2 Million to Expand into Cannabis Industry
ACCESSWIRE - Fri Jul 25, 8:41AM CDT
WHITEFISH, MT / July 25, 2014 / The U.S. cannabis industry grew 64% in 2013 and is expected to reach $2.34 billion by the end of 2014, according to ArcView Market Research. So far, 23 U.S. states and Washington D.C. have legalized medical marijuana, while Colorado and Washington State have legalized recreational marijuana. These trends are poised to continue in the November general election with several outstanding ballot measures in place.
GWPH: 75.63 (-0.21), SIRI: 3.53 (+0.02), GPX: 32.01 (+0.44)
